Research Center Profile: Ancilla, LLC
Center Information
Kathy Autry or Stacy ElledgeDirectors Business DevelopmentAncilla, LLC755 Mount Vernon Highway, Suite 200Sandy Springs, GA 30328USA404-257-8671 or 404-257-8672404-943-0926 (fax)kautry@ancillaservices.com; Sellledge@ancillaservices.comView MapContact Center
Currently Enrolling Trials
[Show More]
Cardiology/Vascular Diseases Dermatology Devices Endocrinology Family Medicine Gastroenterology Healthy Volunteers Immunology Infections and Infectious Diseases Internal Medicine Nephrology Neurology Nutrition and Weight Loss Obstetrics/Gynecology (Women’s Health) Psychiatry/Psychology Pulmonary/Respiratory Diseases Trauma (Emergency, Injury, Surgery) Urology Vaccines
Ancilla, LLC provides business development services to independent research sites. We represent experienced investigators with active sites conducting Phase I-IV clinical trials. Ancilla’s role is to match up site capabilities with protocols requirements, so that the end result is success for the sponsor, the CRO, and the site. There are no fees for the CRO or pharmaceutical company when placing a trial at a site represented by Ancilla. Ancilla is not a “Site Management Organization” (SMO).
Ancilla is only active in the initial site selection process. Once a site is awarded a study sponsors and CRO’s have direct contact with each site at all times. We choose to represent sites based on their ability to enroll and conduct trials successfully, within sponsor timelines. Each investigator we represent has a proven history of meeting and/or exceeding enrollment goals while maintaining quality data. Most study patients are recruited from investigators’ private practices assuring high compliance and retention rates.
Our investigator sites participate in Phase I-IV clinical trials in most therapeutic areas, including both out-patient and in-patient trials. Many sites have experience in conducting device trials as well. On average our investigators and study staff have over 10 years clinical research experience in most therapeutic areas.
Most investigators have active private practices, or group practices, near or within a dedicated research facility. Sites have 2 to 6 full-time coordinators as well as regulatory and patient scheduling specialists. Regulatory documents are submitted within 3-5 days of receipt, and budget/contract negotiations are completed within 72 hours.
Sites with Phase I units have up to 36 beds and are able to conduct all types of Phase I trials, including normal healthy and special population trials.
All facilities have up to date equipment for each therapeutic area in which they conduct trials. At a minimum this includes freezers, refrigerators, 12-lead ECG machines, centrifuge, and other laboratory equipment. Each site has the ability to perform study related diagnostic procedures including radiology (mammogram, ultrasound, MRI/CT, x-ray), pulmonary testing, GI (endoscopy, colonoscopy, flexible sigmoidosocopy), cystometry, as well as most other out-patient procedures. Procedures are either done on site or within 2 miles of the site.
All sites have ample drug storage space and comfortable areas for monitoring visits. Conveniences available to monitors including a telephone, fax machine, photocopier, and internet access.
Ancilla represents sites in the following locations:
Sites have experience in all indications of the following therapeutic areas:
The staff of each clinical site includes board certified physicians, nurse practitioners, registered nurses, medical technicians, and support personnel trained in conducting clinical trails according to GCP guidelines.
Coordinators have up to 15 years research experience in many therapeutic areas.
All sites have experience with electronic data capture, electronic diaries, etc.
For more information:
If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the email form below. A representative from the research center will then follow up with you.